When given via nebuliser to COPD patients, there is a significant reduction in both central and peripheral exhaled NO, although it does not completely block exhaled NO, suggesting that neuronal NOS may be responsible and indicating that selective iNOS inhibitors may not completely reduce peroxynitrite in COPD [114]. This evidence concerns the gene NOS1 and chronic obstructive pulmonary disease.